Evidence map›Paper›PMID 19172689›Full record

ReviewNature reviews. Drug discovery2008

Perspectives on NMR in drug discovery: a technique comes of age.

Maurizio Pellecchia, Ivano Bertini, David Cowburn, Claudio Dalvit, Ernest Giralt, Wolfgang Jahnke, Thomas L James, Steve W Homans, Horst Kessler, Claudio Luchinat and 5 more

Abstract readReview
In one paragraph

Review in Nature reviews. Drug discovery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A ComprehensiveAngewandte Chemie (International ed. in English) · 2026
    Article
  3. CSAKD: Determining Absolute Ligand Affinities FromAngewandte Chemie (International ed. in English) · 2026
    Article
  4. Article
  5. Review
  6. CharacterizingMolecular pharmaceutics · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. NMRRSC medicinal chemistry · 2024
    Article
  13. Article
  14. Review
  15. Optically Enhanced Solid-StateJournal of the American Chemical Society · 2023
    Article
  16. Article
  17. A Flexible, Modular Platform for Multidimensional Ion Mobility of Native-like Ions.Journal of the American Society for Mass Spectrometry · 2023
    Article
  18. Article
  19. FirstTheranostics · 2023
    Article
  20. Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maurizio PellecchiaBurnham Institute for Medical Research, La Jolla, California 92037, USA. mpellecchia@burnham.org
Ivano Bertini
David Cowburn
Claudio Dalvit
Ernest Giralt
Wolfgang Jahnke
Thomas L James
Steve W Homans
Horst Kessler
Claudio Luchinat
Bernd Meyer
Hartmut Oschkinat
Jeff Peng
Harald Schwalbe
Gregg Siegal

Funding

Virulence Factors and Cell DeathP01AI055789 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REED, JOHN C · 2004 to 2008
$15.5M
Structural Biology of Protein KinasesR01GM047021 · NIGMS · ROCKEFELLER UNIVERSITY · PI COWBURN, DAVID · 1992 to 2008
$2.4M
NIAID NIH HHS P01 AI055789NIGMS NIH HHS R01 GM047021
6 · The paper itself

Abstract

In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly appreciated in academia and industry. In this Perspective, we highlight some of the major applications of NMR in drug discovery, focusing on hit and lead generation, and provide a critical analysis of its current and potential utility.

Indexed as

Drug Delivery SystemsDrug DesignDrug DiscoveryDrug Evaluation, PreclinicalDrug IndustryNuclear Magnetic Resonance, Biomolecular

Identifiers

PMID19172689
PMCPMC2891904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.